Sökning: onr:"swepub:oai:gup.ub.gu.se/153848" >
Can changes in sex ...
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
-
Odlind, Viveca (författare)
-
- Milsom, Ian, 1950 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för obstetrik och gynekologi,Institute for the Health of Women and Children, Dept of Obstetrics and Gynaecology
-
Persson, Ingemar (författare)
-
visa fler...
-
Victor, Arne (författare)
-
visa färre...
-
(creator_code:org_t)
- 2002
- 2002
- Engelska.
-
Ingår i: Acta obstetricia et gynecologica Scandinavica. - 0001-6349. ; 81:6, s. 482-90
- Relaterad länk:
-
https://gup.ub.gu.se...
Abstract
Ämnesord
Stäng
- Recent studies have indicated that the risk of thromboembolic disease (VTE) in users of combined oral contraceptive pills (COCs) varies not only with estrogen dose, but also with the progestogen in pills with the same estrogen dose. The aim of this article is to discuss sex hormone binding globulin (SHBG) as a marker of estrogenicity and as a surrogate indicator for the potential risk of VTE in users of COC.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
Nyckelord
- Biological Markers
- blood
- Contraceptives
- Oral
- Combined
- adverse effects
- Cyproterone Acetate
- Desogestrel
- Female
- Humans
- Levonorgestrel
- Norgestrel
- analogs & derivatives
- Norpregnenes
- Predictive Value of Tests
- Risk Factors
- Sex Hormone-Binding Globulin
- metabolism
- Venous Thrombosis
- chemically induced
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas